Health ❯Healthcare

Clinical Trials

Drug Development Drug Efficacy Phase 3 Trials Patient Outcomes Randomized Controlled Trials Research Studies Cancer Research Drug Approval Phase III Trials Efficacy Studies

Gedatolisib Therapy Cuts Advanced Breast Cancer Progression by Up to 76% as Shares Soar

An FDA submission is planned for Q4 2025 based on today’s wild-type cohort findings.

Floss-Based Vaccine Delivery Advances Toward Clinical Trials

GSK Secures Ex-China Rights to 12 Hengrui Drug Programmes in $12.5 Billion Deal

YCT-529 Advances to Extended Human Trials After Clearing Initial Safety Test

Regulators Halt Elevidys Gene Therapy Worldwide After Safety Failures

EU Backs First Twice-Yearly Injectable for HIV Prevention

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

EMA Recommends Restricted Approval for Eli Lilly’s Alzheimer’s Drug Kisunla

EMA Committee Recommends EU Approval for First Oral Postpartum Depression Treatment

Phase 3 Trial Validates Low-Dose Olanzapine for Chemo-Induced Nausea Without Heavy Sedation

Dana-Farber Study Calls for Fusion-Specific Testing in NUT Carcinoma Diagnosis

Wake Forest Plans Expanded Trials After PET Study Validates Intranasal Insulin Delivery

Validated AI Model for Cirrhosis Mortality Risk Rolled Out to Hospitals Worldwide

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

Sarepta Temporarily Halts Elevidys Shipments Under FDA Request

Anti-CD117 Antibody Regimen Enables Chemo-Free Stem Cell Transplants in Children with Fanconi Anemia

NHS to Deploy Single-Dose RSV Antibody Jab for 7,000 Preterm and High-Risk Infants

Prime Editing Reverses Rare Childhood Brain Disorder by Correcting Multiple Mutations in Mice

UF Researchers Develop Universal mRNA Vaccine That Primes Immune System Against Tumors